Addressing Transplant Candidacy When Evaluating Safety of Direct Oral Anticoagulant Agents in Patients on Hemodialysis
- PMID: 34410934
- PMCID: PMC8729849
- DOI: 10.1681/ASN.2021060814
Addressing Transplant Candidacy When Evaluating Safety of Direct Oral Anticoagulant Agents in Patients on Hemodialysis
Keywords: anticoagulation; drug metabolism; kidney transplantation; renal dialysis.
Comment in
-
Authors' Reply.J Am Soc Nephrol. 2021 Sep;32(9):2390-2391. doi: 10.1681/ASN.2021060866. Epub 2021 Aug 18. J Am Soc Nephrol. 2021. PMID: 34410935 Free PMC article. No abstract available.
Comment on
-
Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial.J Am Soc Nephrol. 2021 Jun 1;32(6):1474-1483. doi: 10.1681/ASN.2020111566. Epub 2021 Mar 22. J Am Soc Nephrol. 2021. PMID: 33753537 Free PMC article. Clinical Trial.
References
-
- Lamperti M, Khozenko A, Kumar A: Perioperative management of patients receiving new anticoagulants. Curr Pharm Des 25: 2149–2157, 2019 - PubMed
-
- Lichvar AB, Pierce DR, Salerno D, Klem P, Waldman G, Park JM: Utilization of direct-acting oral anticoagulation in solid organ transplant patients: A national survey of institutional practices. Clin Transplant 34: e13853, 2020 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical